These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34476527)

  • 41. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI.
    Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH
    AJR Am J Roentgenol; 2015 Sep; 205(3):W328-34. PubMed ID: 26295669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic value of lymph node dissection at radical prostatectomy: a population-based case-cohort study.
    Withrow DR; DeGroot JM; Siemens DR; Groome PA
    BJU Int; 2011 Jul; 108(2):209-16. PubMed ID: 21044247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The factors that affect the prediction of lymph node metastasis in prostate cancer.
    Turk H; Ün S; Koca O; Cinkaya A; Kodaz H; Zorlu F
    J Cancer Res Ther; 2018; 14(5):1094-1098. PubMed ID: 30197355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
    Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
    Peneau M; Villers A; Molinié V; Theis D; Soulié M
    Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression.
    Grivas N; Wit E; Pos F; de Jong J; Vegt E; Bex A; Hendricksen K; Horenblas S; KleinJan G; van Rhijn B; van der Poel H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):347-354. PubMed ID: 28068243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series.
    Abdollah F; Cozzarini C; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Salonia A; La Macchia M; Di Muzio N; Rigatti P; Montorsi F; Briganti A
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):624-9. PubMed ID: 22099031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.
    Passoni NM; Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Fossati N; Gandaglia G; Salonia A; Freschi M; Rigatti P; Montorsi F; Briganti A
    Urol Oncol; 2014 Jan; 32(1):29.e21-8. PubMed ID: 23490908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there a relationship between the number of lymph nodes and disease parameters in patients who underwent retropubic prostatectomy.
    Demir A; Karadağ MA; Türkeri L
    Int Urol Nephrol; 2014 Aug; 46(8):1537-41. PubMed ID: 24664551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indications for laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
    Patel MI; Katelaris PM
    Aust N Z J Surg; 1995 Apr; 65(4):233-6. PubMed ID: 7536410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer?
    Sivaraman A; Benfante N; Touijer K; Coleman J; Scardino P; Laudone V; Eastham J
    Investig Clin Urol; 2018 Mar; 59(2):83-90. PubMed ID: 29520383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of pelvic lymph node status in prostate cancer: review of 1690 cases.
    Maccio L; Barresi V; Domati F; Martorana E; Cesinaro AM; Migaldi M; Iachetta F; Ieni A; Bonetti LR
    Intern Emerg Med; 2016 Apr; 11(3):399-404. PubMed ID: 26875178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sentinel lymph node dissection in more than 1200 prostate cancer cases: rate and prediction of lymph node involvement depending on preoperative tumor characteristics.
    Winter A; Kneib T; Henke RP; Wawroschek F
    Int J Urol; 2014 Jan; 21(1):58-63. PubMed ID: 23659488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.
    Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S
    Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Significance and Importance of Pelvic Lymphadenectomy in Low-Risk Prostate Cancer Patients].
    Janßen I; Naumann CM; Hamann M; Knüpfer S; Jünemann KP; Osmonov DK
    Aktuelle Urol; 2016 Sep; 47(5):402-7. PubMed ID: 27680192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Herlemann A; Wenter V; Kretschmer A; Thierfelder KM; Bartenstein P; Faber C; Gildehaus FJ; Stief CG; Gratzke C; Fendler WP
    Eur Urol; 2016 Oct; 70(4):553-557. PubMed ID: 26810345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG; Stone NN; Ianuzzi C; Unger P
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.